Cargando…
Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2
Osteolytic bone lesions are one of the central features of multiple myeloma (MM) and lead to bone pain, fractures, decreased quality of life, and decreased survival. Dysfunction of the osteoclast (OC)/osteoblast (OB) axis plays a key role in the development of myeloma-associated osteolytic lesions....
Autores principales: | Yen, Chia-Hung, Hsu, Chin-Mu, Hsiao, Samuel Yien, Hsiao, Hui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555756/ https://www.ncbi.nlm.nih.gov/pubmed/32937821 http://dx.doi.org/10.3390/ijms21186723 |
Ejemplares similares
-
Pathogenesis and Treatment of Myeloma-Related Bone Disease
por: Gau, Yuh-Ching, et al.
Publicado: (2022) -
Management of Myeloma Bone Lesions
por: Du, Jeng-Shiun, et al.
Publicado: (2021) -
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
por: Yen, Chia-Hung, et al.
Publicado: (2018) -
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
por: Hsu, Chin-Mu, et al.
Publicado: (2022) -
Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Yi-Chang, et al.
Publicado: (2021)